ETS Nederland strives to facilitate a rapid and high-quality product development process through exceptional consultancy and contract research services, delivered in close cooperation with R&D departments of pharmaceutical, biotechnology and agrochemical companies. Led by toxicology expert Dr. Henk Tennekes, ETS Nederland mediates between Sponsor and CRO, objectively selects CROs that best suit the needs of the Sponsor, and gives the Sponsor actionable insights into the true costs.

Toxicology Expertise

Dr. Henk Tennekes has authored many important papers on chemical risk assessment, and he was one of the first scientists to recognize the environmental hazards of neonicotinoid insecticides. His groundbreaking work with these pesticides played an important role in bringing about bans on neonicotinoids in Europe.

Dr. Tennekes was Secretary of the Toxicology Section of the Swiss Society of Pharmacology and Toxicology from 1992-1998 and a Member of the Board of Directors of the Swiss Register of Toxicologists from 1996-2000. He is an Overseas Fellow of the Royal Society of Medicine since 2017.

Design of R&D programmes

ETS Nederland provides dependable advice on design of R&D programmes. In the current race to find treatment options for the coronavirus pandemic (COVID-19), monoclonal antibodies (to neutralize the virus), vaccines and antivirals, or repurposing of existing drugs to treat the infection are all possible options. ETS Nederland can advise on the different R&D programmes for each of these treatment options to ensure rapid development.

CRO Selection

For pharmaceutical companies, outsourcing to Contract Research Organizations (CROs) is an integral part of the drug development process. But with more than 1,100 CROs in the world selecting the right CRO can be really tricky. Based on extensive CRO selection experience ETS Nederland can help you ensure that the chosen CRO has the required expertise and is offering good value for money.

Services

Other toxicology consultancy services include:

• Study design, protocol review and monitoring of in vivo and in vitro studies (ADME, toxicology, and secondary pharmacology).
• Pharmacokinetic (PK) and toxicology data analysis and reporting.
• Preparation of expert reports.
• PK summaries.
• Toxicology summaries.
• Contributions to
• Investigator’s Brochures (IB).
• Investigational New Drugs (IND).
• New Drug Applications (NDA).
• Dossiers According to Directive 91/414/EEC.
• Biocidal Product Directive 98/8/EC, etc.
• The preparation of manuscripts for scientific journals (ghostwriting).

Track Record 

ETS Experimental Toxicology Services Nederland BV has served leading companies in the pharmaceutical and agrochemical industry in Western Europe over nearly 30 years with an excellent record of achievement. Further information is provided on request.

Contact

Dr. Henk A. Tennekes
ETS Nederland BV
Laan van Hilbelink 95-113
7101WL Winterswijk, The Netherlands

E-mail:   info@toxicology.nl
Mobile: +31 (0) 6 2816 1078
www.toxicology.nl

Dr. Henk A. Tennekes

ETS Nederland BV

Laan van Hilbelink 95-113
7101WL Winterswijk
The Netherlands

Mobile: +31 628 16 10 78
Email: info@toxicology.nl

www.toxicology.nl